methodology

De Novo Drug Discovery

De Novo Drug Discovery is a computational and experimental approach to designing novel therapeutic compounds from scratch, without relying on existing molecules or natural products. It involves using algorithms, molecular modeling, and AI to generate and optimize chemical structures that target specific biological pathways or proteins. This methodology aims to create entirely new drugs with improved efficacy, selectivity, and safety profiles compared to traditional drug discovery methods.

Also known as: De Novo Design, De Novo Drug Design, Computer-Aided De Novo Design, AI-Driven Drug Discovery, Structure-Based Drug Design
🧊Why learn De Novo Drug Discovery?

Developers should learn De Novo Drug Discovery when working in pharmaceutical research, biotechnology, or computational chemistry to accelerate the creation of innovative treatments for diseases with unmet medical needs. It is particularly valuable for targeting novel biological mechanisms, overcoming drug resistance, or designing molecules with specific properties like reduced side effects. Use cases include developing cancer therapies, antibiotics for resistant bacteria, and treatments for rare genetic disorders.

Compare De Novo Drug Discovery

De Novo Drug Discovery vs High Throughput Screening→De Novo Drug Discovery vs Fragment Based Drug Discovery→De Novo Drug Discovery vs Natural Product Discovery→

Learning Resources

📄
De Novo Drug Design: Methods and Applications
docs
→
🎓
Coursera: AI in Drug Discovery
course
→
📝
De Novo Design Tutorial by Schrödinger
tutorial
→
📚
Book: De Novo Molecular Design
book
→
🎬
YouTube: Introduction to De Novo Drug Discovery
video
→

Related Tools

Computational ChemistryMachine LearningMolecular DockingCheminformaticsBioinformatics

Alternatives to De Novo Drug Discovery

High Throughput ScreeningFragment Based Drug DiscoveryNatural Product Discovery